000 02854 am a22003253u 4500
042 _adc
100 1 0 _aCohen, Zachary D.
_eauthor
_92496
700 1 0 _aDeRubeis, Robert J.
_eauthor
_92497
700 1 0 _aHayes, Rachel
_eauthor
_92498
700 1 0 _aWatkins, Edward R.
_eauthor
_92499
700 1 0 _aLewis, Glyn
_eauthor
_92500
700 1 0 _aByng, Richard
_eauthor
_92501
700 1 0 _aByford, Sarah
_eauthor
_92502
700 1 0 _aCrane, Catherine
_eauthor
_92503
700 1 0 _aKuyken, Willem
_eauthor
_92504
700 1 0 _aDalgleish, Tim
_eauthor
_91970
700 1 0 _aSchweizer, Susanne
_eauthor
_91969
245 0 0 _aThe Development and Internal Evaluation of a Predictive Model to Identify for Whom Mindfulness-Based Cognitive Therapy Offers Superior Relapse Prevention for Recurrent Depression Versus Maintenance Antidepressant Medication
260 _bSAGE Publications,
_c2022-04-29.
500 _a/pmc/articles/PMC7614103/
500 _a/pubmed/36698442
520 _aDepression is highly recurrent, even following successful pharmacological and/or psychological intervention. We aimed to develop clinical prediction models to inform adults with recurrent depression choosing between antidepressant medication (ADM) maintenance or switching to mindfulness-based cognitive therapy (MBCT). Using previously published data (N = 424), we constructed prognostic models using elastic-net regression that combined demographic, clinical, and psychological factors to predict relapse at 24 months under ADM or MBCT. Only the ADM model (discrimination performance: area under the curve [AUC] = .68) predicted relapse better than baseline depression severity (AUC = .54; one-tailed DeLong's test: z = 2.8, p = .003). Individuals with the poorest ADM prognoses who switched to MBCT had better outcomes compared with individuals who maintained ADM (48% vs. 70% relapse, respectively; superior survival times, z = −2.7, p = .008). For individuals with moderate to good ADM prognoses, both treatments resulted in similar likelihood of relapse. If replicated, the results suggest that predictive modeling can inform clinical decision-making around relapse prevention in recurrent depression.
540 _a© The Author(s) 2022
540 _ahttps://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
546 _aen
690 _aEmpirical Articles
_92505
655 7 _aText
_2local
786 0 _nClin Psychol Sci
856 4 1 _uhttp://dx.doi.org/10.1177/21677026221076832
_zConnect to this object online.
999 _c2294
_d2294